Variant report
Variant | nsv971570 |
---|---|
Chromosome Location | chr7:126753415-126757393 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GRM8 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558055579 | chr7:126753445-126753446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573008485 | chr7:126753463-126753464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111835382 | chr7:126753494-126753495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17865555 | chr7:126753501-126753502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13309000 | chr7:126753528-126753529 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs66659162 | chr7:126753529-126753530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367926359 | chr7:126753535-126753536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142957104 | chr7:126753544-126753545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192819462 | chr7:126753597-126753598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184385217 | chr7:126753600-126753601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562607216 | chr7:126753654-126753655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs13239559 | chr7:126753700-126753701 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs545025487 | chr7:126753702-126753703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572931291 | chr7:126753721-126753722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11563716 | chr7:126753750-126753751 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs73720662 | chr7:126753775-126753776 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs77250127 | chr7:126753820-126753821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549599456 | chr7:126753865-126753866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372310735 | chr7:126753918-126753919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561445250 | chr7:126753989-126753990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555480796 | chr7:126753990-126753991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189345024 | chr7:126753993-126753994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374160077 | chr7:126754049-126754050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372620018 | chr7:126754084-126754085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191341725 | chr7:126754100-126754101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147124765 | chr7:126754121-126754122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567234124 | chr7:126754167-126754168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28948974 | chr7:126754194-126754195 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs566800340 | chr7:126754195-126754196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17867388 | chr7:126754197-126754198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533844261 | chr7:126754290-126754291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374585428 | chr7:126754321-126754322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185053701 | chr7:126754330-126754331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189434980 | chr7:126754377-126754378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201878786 | chr7:126754393-126754394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556240263 | chr7:126754398-126754399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73720663 | chr7:126754408-126754409 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs17864962 | chr7:126754410-126754411 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs560282712 | chr7:126754427-126754428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181759340 | chr7:126754446-126754447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542936766 | chr7:126754447-126754448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141962010 | chr7:126754458-126754459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116309002 | chr7:126754500-126754501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550352537 | chr7:126754548-126754549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549150218 | chr7:126754558-126754559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17868890 | chr7:126754597-126754598 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs185917734 | chr7:126754600-126754601 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs368643034 | chr7:126754670-126754671 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs150663595 | chr7:126754691-126754692 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs113704410 | chr7:126754711-126754712 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Prostate cancer | 22341455 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126753400-126755400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr7:126754000-126755200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
3 | chr7:126754200-126755400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr7:126754400-126755200 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr7:126754400-126755200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:126754400-126755200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr7:126754400-126755400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:126754400-126755400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr7:126755000-126755200 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr7:126755000-126755400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr7:126755800-126756000 | Enhancers | H1 Cell Line | embryonic stem cell |